Paratek Pharmaceuticals Overview
- Year Founded
-
1996
- Status
-
Private
- Employees
-
275
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
18
- Investments
-
1
Paratek Pharmaceuticals General Information
Description
Paratek Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's medical research is based on tetracycline chemistry and biology to create two antibacterials: omadacycline and sarecycline. NUZYRA (Omadacycline) is an antibacterial for skin infections and treatment of community-acquired bacterial pneumonia. SEYSARA (Sarecycline) is designed for use in the treatment of acne and rosacea. Paratek Pharmaceuticals is also involved in research to treat multiple sclerosis, spinal muscular atrophy, and systemic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel diseases.
Contact Information
Website
www.paratekpharma.comCorporate Office
- 1000 First Avenue
- Suite 200
- King of Prussia, PA 19406
- United States
Corporate Office
- 1000 First Avenue
- Suite 200
- King of Prussia, PA 19406
- United States
Paratek Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Paratek Pharmaceuticals Comparisons
Industry
Financing
Details
Paratek Pharmaceuticals Competitors (76)
One of Paratek Pharmaceuticals’s 76 competitors is Neuren Pharmaceuticals, a Corporation company based in Camberwell, Australia.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Neuren Pharmaceuticals | Corporation | Camberwell, Australia | ||||
| Mesoblast | Corporation | Melbourne, Australia | ||||
| Amyndas Pharmaceuticals | Accelerator/Incubator Backed | Bala Cynwyd, PA | ||||
| Scynexis | Formerly VC-backed | Jersey City, NJ | ||||
| Spero Therapeutics | Formerly VC-backed | Cambridge, MA |
Paratek Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Paratek Pharmaceuticals Patents
Paratek Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3179596-A1 | Crystalline forms of omadacycline, methods of synthesis thereof and methods of use thereof | Pending | 11-Jun-2020 | ||
| AU-2021288202-A1 | Crystalline forms of omadacycline, methods of synthesis thereof and methods of use thereof | Pending | 11-Jun-2020 | ||
| EP-4165016-A1 | Crystalline forms of omadacycline, methods of synthesis thereof and methods of use thereof | Pending | 11-Jun-2020 | ||
| US-20230357135-A1 | Crystalline forms of omadacycline, methods of synthesis thereof and methods of use thereof | Pending | 11-Jun-2020 | ||
| EP-4165016-A4 | Crystalline forms of omadacycline, methods of synthesis thereof and methods of use thereof | Pending | 11-Jun-2020 | C07C231/24 |
Paratek Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Paratek Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Paratek Pharmaceuticals Acquisitions (1)
Paratek Pharmaceuticals’s most recent deal was a Merger/Acquisition with Transcept Pharmaceuticals for . The deal was made on 30-Oct-2014.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Transcept Pharmaceuticals | 30-Oct-2014 | Merger/Acquisition | Pharmaceuticals |
Paratek Pharmaceuticals FAQs
-
When was Paratek Pharmaceuticals founded?
Paratek Pharmaceuticals was founded in 1996.
-
Where is Paratek Pharmaceuticals headquartered?
Paratek Pharmaceuticals is headquartered in King of Prussia, PA.
-
What is the size of Paratek Pharmaceuticals?
Paratek Pharmaceuticals has 275 total employees.
-
What industry is Paratek Pharmaceuticals in?
Paratek Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Paratek Pharmaceuticals a private or public company?
Paratek Pharmaceuticals is a Private company.
-
What is the current valuation of Paratek Pharmaceuticals?
The current valuation of Paratek Pharmaceuticals is .
-
What is Paratek Pharmaceuticals’s current revenue?
The current revenue for Paratek Pharmaceuticals is .
-
How much funding has Paratek Pharmaceuticals raised over time?
Paratek Pharmaceuticals has raised $271M.
-
Who are Paratek Pharmaceuticals’s investors?
Tufts University has invested in Paratek Pharmaceuticals.
-
Who are Paratek Pharmaceuticals’s competitors?
Neuren Pharmaceuticals, Mesoblast, Amyndas Pharmaceuticals, Scynexis, and Spero Therapeutics are some of the 76 competitors of Paratek Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
